Keywords: prostrakan, half-year, sales, up, l16, 1m, scottish
ProStrakan half-year sales up 28% to L16.1M
Article | 25 September 2006
Scottish drugmaker ProStrakan says that, for the half year ended June 30, 2006, its total sales were L16.3 million ($30.7 million), down slightly ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
